US Broker Ratings

Niagen Bioscience, Inc. (NAGE) Stock Analysis: Exploring a Potential 150% Upside for Investors

Niagen Bioscience, Inc. (NAGE), operating in the rapidly evolving biotechnology sector, presents a compelling investment thesis with its strong growth potential and notable market positioning. Headquartered in Los Angeles, California,..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Growth Potential Amidst Strong Revenue Performance

Phibro Animal Health Corporation (NASDAQ: PAHC), a stalwart in the healthcare sector, particularly in the specialty and generic drug manufacturing industry, has been capturing investor attention with its robust revenue..

Ardelyx, Inc. (ARDX) Stock Analysis: Exploring 87.5% Potential Upside in Biotech

Ardelyx, Inc. (NASDAQ: ARDX) is making waves in the biotechnology sector with its innovative approach to treating unmet medical needs. Headquartered in Waltham, Massachusetts, Ardelyx has captured investor attention, not..

Nutex Health Inc. (NUTX) Stock Analysis: Exploring a 52% Potential Upside

For investors with a keen eye on the healthcare sector, Nutex Health Inc. (NASDAQ: NUTX) presents a compelling opportunity, boasting a market capitalization of $1.16 billion. As a prominent player..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Riding a 24.97% Potential Upside in the Healthcare Sector

U.S. Physical Therapy, Inc. (NYSE: USPH), a prominent player in the healthcare sector, is attracting considerable attention from investors due to its compelling growth prospects and robust operational framework. With..

NeoGenomics, Inc. (NEO) Stock Analysis: Assessing a 16.59% Potential Upside

NeoGenomics, Inc. (NASDAQ: NEO) is garnering attention in the investment community with a promising 16.59% potential upside, according to recent analyst ratings. With its market cap standing at $1.62 billion,..

Wave Life Sciences Ltd. (WVE) Stock Analysis: A Biotech Gem with 129% Upside Potential

Wave Life Sciences Ltd. (NASDAQ: WVE) is a trailblazing entity in the biotechnology sector, operating out of Singapore with a focus on innovative RNA medicines. As the market cap of..

Evolent Health, Inc. (EVH) Stock Analysis: A 131% Potential Upside Amidst Sector Challenges

Evolent Health, Inc. (NYSE: EVH), a prominent player in the healthcare sector, specifically in health information services, has captured investor attention with an impressive potential upside of 131.33%. Despite recent..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Unveiling a 54% Upside Potential in the Biotech Arena

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is capturing the attention of investors within the biotechnology sector, offering a noteworthy potential upside of 54.26% according to analyst ratings. The company, headquartered in..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: A Healthcare Marvel with 25% Upside Potential

Establishment Labs Holdings Inc (NASDAQ: ESTA), a rising star in the healthcare sector, is attracting significant attention from investors. Headquartered in Alajuela, Costa Rica, this medical technology company specializes in..

Innoviva, Inc. (INVA) Stock Analysis: Exploring a 67% Potential Upside in the Biotechnology Sector

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the healthcare sector, particularly within the biotechnology industry, is currently capturing investor interest with a potential upside of 67.18%, according to analyst..

The Pennant Group, Inc. (PNTG) Growth Potential: Analysts Forecast a Robust 29.94% Upside

The Pennant Group, Inc. (NASDAQ: PNTG), a prominent player in the healthcare sector, is garnering significant attention from investors as it carves out a niche in the medical care facilities..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 29.59% Potential Upside in Non-Opioid Pain Management Solutions

Pacira BioSciences, Inc. (NASDAQ: PCRX), a prominent player in the healthcare sector, is gaining attention from investors with its innovative approach to pain management. Specializing in non-opioid solutions, Pacira BioSciences..

Adaptive Biotechnologies Corp (ADPT) Stock Analysis: Revenue Growth Surges Over 100%, Analysts Eye 9.53% Upside

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) is capturing the attention of investors with its remarkable revenue growth and promising analyst ratings. As a key player in the biotechnology sector, this Seattle-based..

UFP Technologies, Inc. (UFPT)

❌ Error generating article: Server error: `POST https://api.openai.com/v1/chat/completions` resulted in a `502 Bad Gateway` response: 502 Bad Gateway 502 Bad Gateway clou (truncated…)

..

agilon health, inc. (AGL) Stock Analysis: Navigating the Challenges in Healthcare with a Unique Platform

agilon health, inc. (NASDAQ: AGL) offers a fascinating glimpse into the evolving landscape of healthcare services, particularly focusing on the needs of seniors through a unique platform that partners with..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Exploring a 29.77% Potential Upside in Biotechnology

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is making waves in the biotechnology sector with its innovative approach to tackling metabolic disorders. With a market capitalization of $1.65 billion, this Cambridge, Massachusetts-based..

Integra LifeSciences Holdings C (IART): Investor Outlook with a 17.87% Potential Upside

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the medical devices sector, presents an intriguing opportunity for investors navigating the healthcare landscape. With a market capitalization of $1.02..

Evotec SE (EVO) Stock Analysis: Exploring a Potential 47.54% Upside in a Challenging Landscape

Evotec SE (EVO), a notable player in the healthcare sector, specifically in the specialty and generic drug manufacturing industry, operates on a global scale with its headquarters in Hamburg, Germany...

Premier, Inc. (PINC): Investor Outlook Amidst 2.97% Dividend Yield and Zero Buy Ratings

Premier, Inc. (NASDAQ: PINC), a noteworthy player in the healthcare sector, specializes in health information services. With a market capitalization of $2.34 billion, Premier operates as a healthcare improvement company..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds